ÂÜÀòÂÒÂ×

Mark Weir-Smith is currently the Senior Vice President Quality Operations and Regulatory Affairs at NovaCina, LumaCina, and Bridgewest Perth Pharma. Prior to this, Mark held roles such as Medical Assessor at the National Association of Testing Authorities, WA & NT General Practice Business Operations Leader at Western Diagnostic Pathology, Quality Operations and Regulatory Affairs Site Leader at Pfizer, and Regional Manager at the Australian Red Cross. Mark has also served as Vice President and Board Member at the ISPE Australasia Affiliate. Mark has a background in Science and Medical Science from Curtin University, with additional education in Business Organisational Leadership from Harvard Business School.